TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery?
Ontology highlight
ABSTRACT: The aim of this study is to investigate the potential use of soluble TREM-1 (sTREM-1) to predict serious infectious complications in patients undergoing laparoscopic colorectal surgery. Patients with colon or rectal cancer, who underwent elective laparoscopic colorectal cancer surgery between November 2018 and February 2020 were included into study. Blood samples for the TREM-1 protein assay were collected from each patient four times: preoperatively and on three following postoperative days (PODs).
Patients with infectious complications who formed group 1, were matched 1:1 with patients without complications (group 2). Case-matched analysis was performed by selecting patients for the control group from the group of patients paired by age, ASA scale, stage of cancer and type of surgery.
DISEASE(S): Colorectal (colon Or Rectal) Cancer,Infections,Communicable Diseases,Cancer
PROVIDER: 65605 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA